All NIH Funding Opportunities and Notices

• Summary of Leave, Part-Time and Extension Policies Available to Ruth L. Kirschstein National Research Service Awards (NRSA) Trainees and Fellows
  (NOT-OD-18-154)
  National Institutes of Health
  

• Notice of Application Form Issue with PAR-18-352 "Methodology and Measurement in the Behavioral and Social Sciences (R01 Clinical Trial Optional)"
  (NOT-OD-18-158)
  Office of the Director, NIH
  

• Findings of Research Misconduct
  (NOT-OD-18-159)
  National Institutes of Health
  

• Financial Conflict of Interest: Investigator Disclosures of Foreign Financial Interests
  (NOT-OD-18-160)
  National Institutes of Health
  

• RESCINDED - Registration Process Changes in SAM.gov
  (NOT-OD-18-162)
  National Institutes of Health
  

• Notice of Corrected Application Form for NIAAA PA-18-508 "Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 Clinical Trial Optional)"
  (NOT-AA-18-008)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Correction to PAR-17-287 "NIA Academic Leadership Career Award (K07)"
  (NOT-AG-18-006)
  National Institute on Aging
  

• Notice of NIAID's Interest in Continued Support of High Priority Immunology Grants
  (NOT-AI-18-024)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Information for PA-18-529, " Early-life Factors and Cancer Development Later in Life (R01 Clinical Trial Not Allowed)"
  (NOT-CA-18-058)
  National Cancer Institute
  

• Notice of Change in Eligible Organizations in PA-18-629 Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)" to Allow Foreign Components in Domestic Applications
  (NOT-CA-18-059)
  National Cancer Institute
  

• Notice of NIDCR's participation in PAR-18-714, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed)
  (NOT-DE-18-015)
  National Institute of Dental and Craniofacial Research
  

• Notice of NHLBI Participation in PA-18-702 "Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp - Clinical Trial Not Allowed)"
  (NOT-HL-18-608)
  National Heart, Lung, and Blood Institute
  

• RESCINDED - NHLBI Only Accepts Clinical Trial Applications Proposing Mechanistic Studies in response to the NIH Parent R01 Clinical Trial Required Announcement
  (NOT-HL-18-610)
  National Heart, Lung, and Blood Institute
  

• NHLBI Policy Regarding Submission of Clinical Trial Applications
  (NOT-HL-18-611)
  National Heart, Lung, and Blood Institute
  

• Notice of Application Form Issue for RFA-HL-19-007, "Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) (U01 Clinical Trial Not Allowed)"
  (NOT-HL-18-617)
  National Heart, Lung, and Blood Institute
  

• Notice of NINDS Participation in PAR-18-733 "Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)"
  (NOT-NS-18-051)
  National Institute of Neurological Disorders and Stroke
  

• Notice of NINDS BRG, BRP, Translational Neural Devices, BRAIN Initiative: Next Generation Invasive Devices Recording, Modulation in the Human Central Nervous System, and Smart & Connected Health Program Applications Directed at the Treatment of Pain
  (NOT-NS-18-052)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Participation in PAR-18-721 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)
  (NOT-NS-18-053)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  

• Workshop on the Use of Adolescent Brain Cognitive Development (ABCD) Data (R25 Clinical Trial Not Allowed)
  (RFA-DA-19-006)
  National Institute on Drug Abuse
  National Institute of Mental Health
  Application Receipt Date(s): July 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Exploration of HL7 FHIR Standards for Clinical Research and Post-market Surveillance
  (RFA-FD-18-016)
  Food and Drug Administration
  Application Receipt Date(s): June 11, 2018, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  

• Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (U24 Clinical Trial Not Allowed)
  (RFA-GM-18-003)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)
  (RFA-HL-19-015)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): June 4, 2018, June 4, 2019, June 4, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• NIH Director's Early Independence Award (DP5 - Clinical Trial Optional)
  (RFA-RM-18-010)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 27, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed)
  (PA-18-718)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2018.
  
  

• Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed)
  (PA-18-719)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.The first standard application due date for this FOA is October 5, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
  (PA-18-720)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Dietary Supplements
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)
  (PA-18-722)
  Office of Behavioral and Social Sciences Research
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)
  (PA-18-723)
  Office of Behavioral and Social Sciences Research
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed)
  (PA-18-724)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)
  (PA-18-725)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)
  (PA-18-728)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of AIDS Research
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)
  (PA-18-729)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of AIDS Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)
  (PAR-18-721)
  National Institute of Neurological Disorders and Stroke
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): May 30, 2018; May 28, 2019; June 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
  (PAR-18-726)
  National Eye Institute
  Application Receipt Date(s): June 11, 2018; June 11, 2019; and June 11, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
  (PAR-18-727)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Center for Complementary and Integrative Health
  National Cancer Institute
  Office of Dietary Supplements
  Department of Agriculture
  Application Receipt Date(s): June 11, 2018; September 27, 2018; May 29, 2019, September 27, 2019 and January 27, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
  (PAR-18-731)
  National Cancer Institute
  Application Receipt Date(s): June 19, 2018; November 19, 2018; June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional)
  (PAR-18-732)
  John E. Fogarty International Center
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Not Applicable; See AIDS Application Due Date(s)
  
  

• Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
  (PAR-18-733)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 - Clinical Trial Not Allowed)
  (PAR-18-734)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
  (PAS-18-730)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892